Page 4 - Quarter For Jazz Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quarter for jazz pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quarter For Jazz Pharmaceuticals Today - Breaking & Trending Today

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Purchased by Kendall Capital Management

Kendall Capital Management grew its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 29.9% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 7,799 shares of the specialty pharmaceutical company’s stock after buying an additional 1,795 shares during the quarter. Kendall Capital Management’s holdings in Jazz Pharmaceuticals were worth $959,000 […] ....

New Zealand General , New Zealand , United States , Patricia Carr , Stifel Nicolaus , Philipl Johnson , Jazz Pharmaceuticals Company Profile , Jpmorgan Chase Co , News Ratings For Jazz Pharmaceuticals Daily , Jazz Pharmaceuticals , Vanguard Group Inc , Securities Exchange Commission , Royal Bank , Wellington Management Group , Jazz Pharmaceuticals Price Performance , Quarter For Jazz Pharmaceuticals , Kendall Capital Management , Free Report , Capital Management , Management Group , Street Corp , Get Free Report , Visit Holdingschannel , Jazz Pharmaceuticals Daily , Nasdaq Jazz , Sec Filings ,

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Acquired by Kendall Capital Management

Kendall Capital Management boosted its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 29.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,799 shares of the specialty pharmaceutical company’s stock after purchasing an additional 1,795 shares […] ....

United States , Philipl Johnson , Robertw Baird , Patricia Carr , Needham Company , Vanguard Group Inc , Jazz Pharmaceuticals , Aviva Plc , News Ratings For Jazz Pharmaceuticals Daily , Jpmorgan Chase Co , Exchange Commission , Jazz Pharmaceuticals Company Profile , Us Bancorp , Quarter For Jazz Pharmaceuticals , Jazz Pharmaceuticals Price Performance , Advisor Group , Kendall Capital Management , Free Report , Capital Management , Asset Management Gmbh , Vanguard Group , Get Free Report , Jazz Pharmaceuticals Daily , Nasdaq Jazz , Sec Filings , Hedge Fund Holdings ,

Tributary Capital Management LLC Lowers Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Tributary Capital Management LLC decreased its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,490 shares of the specialty pharmaceutical company’s stock after selling 100 shares during the quarter. Tributary Capital […] ....

United States , Patricia Carr , Robertw Baird , Philipl Johnson , Us Bancorp , Jazz Pharmaceuticals Stock Performance , Securities Exchange Commission , Tributary Capital Management , Quarter For Jazz Pharmaceuticals , Jpmorgan Chase Co , Advisor Group , Jazz Pharmaceuticals , Insider Activity At Jazz Pharmaceuticals , Cantor Fitzgerald , Vanguard Group Inc , News Ratings For Jazz Pharmaceuticals Daily , Aviva Plc , Needham Company , Free Report , Capital Management , Asset Management Gmbh , Vanguard Group , Get Free Report , Exchange Commission , Jazz Pharmaceuticals Daily , Nasdaq Jazz ,

JPMorgan Chase & Co. Cuts Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

JPMorgan Chase & Co. trimmed its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 16.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,426,041 shares of the specialty pharmaceutical company’s stock after selling 270,971 shares during the period. JPMorgan Chase & […] ....

United States , Patricia Carr , Philipl Johnson , News Ratings For Jazz Pharmaceuticals Daily , Securities Exchange Commission , Needham Company , Massmutual Trust Co , Covestor Ltd , Royal Bank , Jazz Pharmaceuticals Trading , Insider Activity At Jazz Pharmaceuticals , Quadrant Capital Group , Quarter For Jazz Pharmaceuticals , St Germaindj Co , Jazz Pharmaceuticals , Jpmorgan Chase Co , Free Report , Wealth Management , Capital Group , Get Free Report , Exchange Commission , Jazz Pharmaceuticals Daily ,

Braun Stacey Associates Inc. Has $14.23 Million Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Braun Stacey Associates Inc. cut its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 8.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 109,924 shares of the specialty pharmaceutical company’s stock after selling 10,563 shares during the period. Braun Stacey Associates Inc.’s holdings in […] ....

United States , Philipl Johnson , Patricia Carr , Robertw Baird , Jazz Pharmaceuticals Stock Down , Needham Company , Us Bancorp , Jazz Pharmaceuticals , Securities Exchange Commission , News Ratings For Jazz Pharmaceuticals Daily , Jazz Pharmaceuticals Company Profile , Quarter For Jazz Pharmaceuticals , Advisor Group , Aviva Plc , Braun Stacey Associates Inc , Vanguard Group Inc , Braun Stacey Associates , Free Report , Stacey Associates , Asset Management Gmbh , Vanguard Group , Truist Financial , Exchange Commission , Pharmaceuticals Stock Down , Get Free Report , Visit Holdingschannel ,